scholarly article | Q13442814 |
P2093 | author name string | P A Campochiaro | |
M Küchle | |||
W R Green | |||
C Chiu | |||
J Mahlow | |||
S A Vinores | |||
P2860 | cites work | Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients | Q72341456 |
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells | Q72391861 | ||
Retinal trypsin digest study of cystoid macular edema associated with peripheral choroidal melanoma | Q72437475 | ||
Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome | Q72684582 | ||
Choroidal melanoma with disc and retinal neovascularization | Q72706937 | ||
Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty | Q72769895 | ||
Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin | Q72772880 | ||
Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema | Q72863272 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics | Q30444967 | ||
Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin | Q30454333 | ||
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts | Q34151181 | ||
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. | Q34292373 | ||
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels | Q34345167 | ||
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis | Q34578752 | ||
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. | Q35796234 | ||
Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells | Q35830379 | ||
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels | Q36230478 | ||
Quantitative assessment of the blood-aqueous barrier in human eyes with malignant or benign uveal tumors | Q36747023 | ||
Vascular permeability factor: A unique regulator of blood vessel function | Q36958542 | ||
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors | Q37370535 | ||
The structural basis of the blood-ocular barriers | Q39869349 | ||
Vascular permeability factor (VPF, VEGF) in tumor biology | Q40801255 | ||
Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? | Q41446853 | ||
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. | Q41481649 | ||
Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the Antibody | Q41533622 | ||
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration | Q41711674 | ||
Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas | Q41866566 | ||
Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. | Q45052632 | ||
Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies | Q46428452 | ||
Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone | Q48173615 | ||
The blood-retinal barriers | Q48356949 | ||
Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. | Q54195980 | ||
Cystoid macular edema with equatorial choroidal melanoma | Q67414763 | ||
Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
Human vascular permeability factor. Isolation from U937 cells | Q69385781 | ||
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines | Q69614850 | ||
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract | Q70487576 | ||
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells | Q70764129 | ||
Hypoxia regulatory elements of the human vascular endothelial growth factor gene | Q71665083 | ||
Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes | Q71738535 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P1104 | number of pages | 9 | |
P304 | page(s) | 1289-1297 | |
P577 | publication date | 1995-11-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor | |
P478 | volume | 147 |
Q37617562 | Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors |
Q43755773 | Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains |
Q33969496 | Cellular mechanisms of blood-retinal barrier dysfunction in macular edema |
Q28365750 | Corneal autofluorescence in choroidal melanoma or in choroidal naevus |
Q31774297 | Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis |
Q81416638 | Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas |
Q36946632 | Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma |
Q43095714 | Increased expression of angiogenic growth factors in age-related maculopathy |
Q35298251 | Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes |
Q33899013 | Macular oedema: the role of soluble mediators |
Q37632849 | Optic disc edema from remote uveal melanoma |
Q44259858 | Retinal vascular alterations associated with dome-shaped and mushroom-shaped choroidal melanomas |
Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
Q34163697 | Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma |
Q35589581 | Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth |
Q35589644 | Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window |
Search more.